Prostate specific antigen testing in men before age 50 can help identify those who are most at risk of developing advanced prostate cancer up to 25 years before the diagnosis, U.S. and Swedish researchers found. The findings could assist doctors in identifying patients who are most likely to benefit from intensive screenings, researchers said.

Full Story:

Related Summaries